SCHEMBL3605347

SCHEMBL3605347

O=C(O)c1cc2c(ccc3ccccc32)o1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 9/20 1.00
HPGD P15428 5/20 1.00
MAPT P10636 4/20 1.00
GLA P06280 3/20 1.00
TDP1 Q9NUW8 3/20 1.00
HTT P42858 2/20 1.00
HSD17B10 Q99714 2/20 1.00
TSHR P16473 1/20 1.00
L3MBTL1 Q9Y468 1/20 1.00
CSNK2A1 P68400 5/20 0.72
PIM1 P11309 4/20 0.72
ALDH1A1 P00352 6/20 0.69
GAA P10253 3/20 0.69
NPC1 O15118 4/20 0.68
RAB9A P51151 4/20 0.68
CSNK2A2 P19784 4/20 0.67
CSNK2B P67870 4/20 0.67
CSNK2A3 Q8NEV1 4/20 0.67
USP2 O75604 1/20 0.60
PTGS1 P23219 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL11652791 0.98 KDM4E (0.97) KDM4EHPGDMAPTGLATDP1
SCHEMBL10412026 0.86 KDM4E (0.76) KDM4EHPGDMAPTGLATDP1
SCHEMBL11110903 0.85 KDM4E (0.74) KDM4EHPGDMAPTGLATDP1
SCHEMBL16795594 0.85 KDM4E (0.73) KDM4EHPGDMAPTGLATDP1
SCHEMBL16271245 0.82 KDM4E (1.00) KDM4EHPGDMAPTGLATDP1
SCHEMBL2807607 0.79 ALDH1A1 (1.00) KDM4EHPGDMAPTGLATDP1
SCHEMBL23351596 0.77 KDM4E (0.62) KDM4EHPGDMAPTGLATDP1
SCHEMBL11111390 0.77 KDM4E (0.62) KDM4EHPGDMAPTGLATDP1
SCHEMBL16271258 0.77 KDM4E (0.70) KDM4EHPGDMAPTGLATDP1
SCHEMBL2895883 0.77 HPGD (0.64) KDM4EHPGDMAPTGLATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9643959-B2 Tubulin polymerization inhibitor and method for synthesizing same KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2017-05-09 US claimed
US-20160102078-A1 NOVEL TUBULIN POLYMERIZATION INHIBITOR AND METHOD FOR SYNTHESIZING SAME KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2016-04-14 US claimed
US-20250346575-A1 ISOINDOLINONE DERIVATIVE HAVING GLUTARIMIDE MOTHER NUCLEUS, AND USE THEREOF KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2025-11-13 US disclosed
EP-4431505-A1 ISOINDOLINONE DERIVATIVE HAVING GLUTARIMIDE MOTHER NUCLEUS, AND USE THEREOF Korea Research Institute of Chemical Technology (KR) 2024-09-18 EP disclosed
WO-2023085785-A1 ISOINDOLINONE DERIVATIVE HAVING GLUTARIMIDE MOTHER NUCLEUS, AND USE THEREOF 한국화학연구원 2023-05-19 WO disclosed
US-9643959-B2 Tubulin polymerization inhibitor and method for synthesizing same KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2017-05-09 US disclosed
US-9643959-B2 Tubulin polymerization inhibitor and method for synthesizing same KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2017-05-09 US disclosed
US-9643959-B2 Tubulin polymerization inhibitor and method for synthesizing same KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2017-05-09 US disclosed
US-20160102078-A1 NOVEL TUBULIN POLYMERIZATION INHIBITOR AND METHOD FOR SYNTHESIZING SAME KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2016-04-14 US disclosed
US-20160102078-A1 NOVEL TUBULIN POLYMERIZATION INHIBITOR AND METHOD FOR SYNTHESIZING SAME KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2016-04-14 US disclosed
US-20160102078-A1 NOVEL TUBULIN POLYMERIZATION INHIBITOR AND METHOD FOR SYNTHESIZING SAME KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2016-04-14 US disclosed
EP-1692124-B1 BIARYL SULFONAMIDES AS MMP INHIBITORS WYETH CORP (US) 2008-10-15 EP disclosed
US-7420001-B2 Biaryl sulfonamides and methods for using same WYETH (US) 2008-09-02 US disclosed
EP-1692124-A1 BIARYL SULFONAMIDES AS MMP INHIBITORS Wyeth (US) 2006-08-23 EP disclosed
WO-2005061477-A1 BIARYL SULFONAMIDES AS MMP INHIBITORS WYETH (US) 2005-07-07 WO disclosed
US-20050143422-A1 Biaryl sulfonamides and methods for using same WYETH (US) 2005-06-30 US disclosed
CN-1623537-A Biaryl sulfonamides and its using method WYETH CORP (US) 2005-06-08 CN disclosed
US-4360679-A OPTICAL BRIGHTENERS CIBA-GEIGY CORPORATION (US) 1982-11-23 US disclosed
US-4250317-A OPTICAL BRIGHTENERS; FLUORESCENT DYES; TEXTILES; DETERGENTS CIBA-GEIGY CORPORATION (US) 1981-02-10 US disclosed
US-4146725-A OPTICAL BRIGHTENERS CIBA-GEIGY CORPORATION (US) 1979-03-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160102078-A1 NOVEL TUBULIN POLYMERIZATION INHIBITOR AND METHOD FOR SYNTHESIZING SAME TUBB1, TUBB, TUBB6 KDM4E 1749/4885HPGD 3658/4885MAPT 48/4885
US-20050143422-A1 Biaryl sulfonamides and methods for using same STS, MMP3, AADAC KDM4E 1421/4885HPGD 1110/4885MAPT 4416/4885
US-20250346575-A1 ISOINDOLINONE DERIVATIVE HAVING GLUTARIMIDE MOTHER NUCLEUS, AND USE THEREOF CRBN, IDH1, IDH2 KDM4E 2129/4885HPGD 1773/4885MAPT 1162/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.